Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer
dc.contributor.author | Elorbany, S | en_US |
dc.contributor.author | Berlato, C | en_US |
dc.contributor.author | Carnevalli, L | en_US |
dc.contributor.author | Maniati, E | en_US |
dc.contributor.author | Wang, J | en_US |
dc.contributor.author | Barry, S | en_US |
dc.contributor.author | Manchanda, R | en_US |
dc.contributor.author | Kzhyshkowska, J | en_US |
dc.contributor.author | Balkwill, F | en_US |
dc.date.accessioned | 2023-05-25T09:57:28Z | |
dc.date.issued | 2023-04-14 | en_US |
dc.identifier.issn | 0008-5472 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/88341 | |
dc.format.extent | lb195 - lb195 | en_US |
dc.publisher | American Association for Cancer Research (AACR) | en_US |
dc.relation.ispartof | Cancer Research | en_US |
dc.subject | Clinical Research | en_US |
dc.subject | Rare Diseases | en_US |
dc.subject | Cancer | en_US |
dc.subject | Immunization | en_US |
dc.subject | Prevention | en_US |
dc.subject | Ovarian Cancer | en_US |
dc.subject | Biotechnology | en_US |
dc.subject | Vaccine Related | en_US |
dc.subject | 2.1 Biological and endogenous factors | en_US |
dc.subject | 2 Aetiology | en_US |
dc.subject | Inflammatory and immune system | en_US |
dc.subject | Cancer | en_US |
dc.title | Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1158/1538-7445.am2023-lb195 | en_US |
pubs.issue | 8_Supplement | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 83 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1179]